Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease
- PMID: 20685658
- PMCID: PMC2943325
- DOI: 10.1074/jbc.C110.158303
Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease
Abstract
A single nucleotide polymorphism (SNP) in codon 129 of the human prion gene, leading to a change from methionine to valine at residue 129 of prion protein (PrP), has been shown to be a determinant in the susceptibility to prion disease. However, the molecular basis of this effect remains unexplained. In the current study, we determined crystal structures of prion segments having either Met or Val at residue 129. These 6-residue segments of PrP centered on residue 129 are "steric zippers," pairs of interacting β-sheets. Both structures of these "homozygous steric zippers" reveal direct intermolecular interactions between Met or Val in one sheet and the identical residue in the mating sheet. These two structures, plus a structure-based model of the heterozygous Met-Val steric zipper, suggest an explanation for the previously observed effects of this locus on prion disease susceptibility and progression.
Figures


Similar articles
-
Conformational diversity in prion protein variants influences intermolecular beta-sheet formation.EMBO J. 2010 Jan 6;29(1):251-62. doi: 10.1038/emboj.2009.333. Epub 2009 Nov 19. EMBO J. 2010. PMID: 19927125 Free PMC article.
-
Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.J Mol Biol. 2011 Sep 30;412(4):660-73. doi: 10.1016/j.jmb.2011.07.067. Epub 2011 Aug 4. J Mol Biol. 2011. PMID: 21839748
-
Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.J Virol. 2014 Mar;88(5):2690-703. doi: 10.1128/JVI.02720-13. Epub 2013 Dec 18. J Virol. 2014. PMID: 24352465 Free PMC article.
-
An inherited prion disease with a PrP P105L mutation: clinicopathologic and PrP heterogeneity.Neurology. 1999 Jul 13;53(1):181-8. doi: 10.1212/wnl.53.1.181. Neurology. 1999. PMID: 10408557 Review.
-
Molecular approaches to mechanisms of prion diseases.Folia Neuropathol. 2004;42 Suppl A:33-46. Folia Neuropathol. 2004. PMID: 15449458 Review.
Cited by
-
The Three Glycotypes in the London Classification System of Sporadic Creutzfeldt-Jakob Disease Differ in Disease Duration.Mol Neurobiol. 2021 Aug;58(8):3983-3991. doi: 10.1007/s12035-021-02396-9. Epub 2021 Apr 26. Mol Neurobiol. 2021. PMID: 33904020
-
Structural evidence for the critical role of the prion protein hydrophobic region in forming an infectious prion.PLoS Pathog. 2019 Dec 9;15(12):e1008139. doi: 10.1371/journal.ppat.1008139. eCollection 2019 Dec. PLoS Pathog. 2019. PMID: 31815959 Free PMC article.
-
Molecular dynamics simulation of temperature induced unfolding of animal prion protein.J Mol Model. 2013 Oct;19(10):4433-41. doi: 10.1007/s00894-013-1955-0. Epub 2013 Aug 8. J Mol Model. 2013. PMID: 23925513
-
Structural insights into functional and pathological amyloid.J Biol Chem. 2011 May 13;286(19):16533-40. doi: 10.1074/jbc.R111.227108. Epub 2011 Mar 25. J Biol Chem. 2011. PMID: 21454545 Free PMC article. Review.
-
N-terminal Prion Protein Peptides (PrP(120-144)) Form Parallel In-register β-Sheets via Multiple Nucleation-dependent Pathways.J Biol Chem. 2016 Oct 14;291(42):22093-22105. doi: 10.1074/jbc.M116.744573. Epub 2016 Aug 30. J Biol Chem. 2016. PMID: 27576687 Free PMC article.
References
-
- Palmer M. S., Dryden A. J., Hughes J. T., Collinge J. (1991) Nature 352, 340–342 - PubMed
-
- Mead S., Stumpf M. P., Whitfield J., Beck J. A., Poulter M., Campbell T., Uphill J. B., Goldstein D., Alpers M., Fisher E. M., Collinge J. (2003) Science 300, 640–643 - PubMed
-
- Kaski D., Mead S., Hyare H., Cooper S., Jampana R., Overell J., Knight R., Collinge J., Rudge P. (2009) Lancet 374, 2128. - PubMed
-
- Alperovitch A., Zerr I., Pocchiari M., Mitrova E., de Pedro Cuesta J., Hegyi I., Collins S., Kretzschmar H., van Duijn C., Will R. G. (1999) Lancet 353, 1673–1674 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous